article thumbnail

Japanese drugmakers make greener packaging pledge

pharmaphorum

Four Japanese drugmakers – Astellas, Eisai, Daiichi Sankyo, and Takeda – have joined forces in a partnership intended to reduce the environmental impact of pharmaceutical packaging. The post Japanese drugmakers make greener packaging pledge appeared first on.

Packaging 104
article thumbnail

Citrate-free HCF of adalimumab biosimilar gets positive opinion

European Pharmaceutical Review

As part of the submission package to the EMA, Sandoz conducted a Phase I pharmacokinetics (PK) bridging study comparing its approved adalimumab 50mg/ml with the 100mg/ml (HCF). In 2015, the EMA and US Food and Drug Administration (FDA) approved Humira ® HCF, which contains adalimumab at a concentration of 100mg/ml.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Chinese manufacturers’ transition to innovative pharma requires more investment

Pharmaceutical Technology

The Chinese government announced its ten-year 'Made in China 2025' strategic plan in 2015, which aimed to make the country a global leader in several high-tech industries. Since 2015, the government has greatly increased its investment and support for biotech to stimulate innovation in the sector.

FDA 64
article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

However, the researchers noted that a larger number of warning letters were issued to pharmaceutical manufacturers (ie, by CDER) than to medical device manufacturers (by CDRH) between 2015 and 2020. The major reasons for this were poor cGMP compliance and misbranding.

FDA 94
article thumbnail

Guide to Medicaid in Pennsylvania

The Checkup by Singlecare

In 2015, Pennsylvania became one of 41 states to adopt the Affordable Care Act (ACA) Medicaid expansion. Eligibility for Pennsylvania Medicaid Since adopting the ACA Medicaid expansion in 2015, Pennsylvania has implemented targeted enrollment strategies to help eligible Pennsylvanians gain coverage. million Pennsylvania residents.

article thumbnail

EMA Annex 1 Q&A discusses bioburden considerations

European Pharmaceutical Review

In its answer, when considering bioburden, EMA shared that the specification limits should be “NMT 10 CFU/100ml”, in line with the guideline sterilisation-medicinal-product and active-substance ref EMA/CHMP/CVMP/QWP/850374/2015. EMA also emphasised the importance of considering the time between sampling, sterilisation and testing.

article thumbnail

FDA approves over-the-counter naloxone

The Checkup by Singlecare

The Narcan nasal spray, manufactured by Emergent BioSolutions, wasn’t granted FDA approval until 2015—but access was restricted to those with a prescription. This delay allows time for manufacturing changes for nonprescription packaging and supply chain modifications. chief medical officer of Toolbox Genomics.

FDA 98